Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Veterinary antibiotic sales halved in five years
There has been an overall fall in the level of resistance in E. coli from healthy pigs at slaughter since 2015.

“This demonstrates how farmers and vets have been working together to use antibiotics responsibly” - Peter Borriello, VMD.

UK antibiotic sales for food-producing animals have fallen by as much as half since 2014, according to the latest UK-Veterinary Antibiotic Resistance and Sales Surveillance (UK-VARSS) annual report.

Published by the Veterinary Medicines Directorate (VMD), the 2019 report shows that sales of antibiotics increased slightly by 1.5 mg/kg to 31.0 mg/kg compared to 2018. This increase was, however, offset by a reduction in the use of the Highest Priority Critically Important Antibiotics (HP-CIAs), which are critical for human health. 

The report, released at the start of World Antimicrobial Awareness Week (18-24 Novermber), also shows that the use of veterinary antibiotics in 2019 was at its second-lowest level since the start of reporting, and the UK has the fifth-lowest level of antibiotic sales in Europe. 

Peter Borriello, chief executive of the VMD said: “In the last five years we have worked closely with the farming industry and veterinary profession to achieve huge reductions in the use of antibiotics in animals.

"This demonstrates how farmers and vets have been working together to use antibiotics responsibly while safeguarding the health and welfare of our livestock.

“The UK Government will continue to work with industry to focus on infection control, reducing the need to use antibiotics to treat disease and maintain the UK’s world-leading standards in animal welfare.”

Reducing the use of unnecessary antibiotics in animals, especially HP-CIAs, is key to halting the spread of antibiotic resistance and protecting the most important antibiotics for human health. However, their use in livestock remains critical to protect against disease.

The report shows that between 2018 and 2019, the use of HP-CIAs in food-producing animals fell by 21 per cent, accounting for 0.5 per cent of total antibiotic sales. Figures show there was also an overall fall in the level of resistance in E. coli from healthy pigs at slaughter since 2015, and resistance to HP-CIAs in E. coli is at very low levels.


Christine Middlemiss, chief veterinary officer for the UK, added: “I am delighted that the UK continues to lead the way as one of the lowest users of antibiotics in livestock across Europe.

“These findings are testament to the hard work of the UK’s farmers and vets to use antibiotics responsibly in order to tackle antibiotic resistance and protect our most critically important antibiotics in human health, while also reducing the burden of disease in animals.”

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.